CIPO Patents = 1

EPO Patents = 3

Forward Citations = 10

Loading Chart...

3 inventors (with patents filed for the assignee):

Mark R Burns (5 out of 6 patents)

Nand Baindur (1 out of 7 patents)

Gerard F Graminski (1 out of 5 patents)

4. Mark Robert Burns (1 patent)

5 patents: Sort by Forward Citations

1. 12364709 - Bioavailable poly amines (2025-07-22),

2. 11865095 - Combination drug substance of polyamine transport inhibitor and DFMO (2024-01-09),

3. 11395834 - Bioavailable polyamines (2022-07-26),

4. 10632145 - Bioavailable polyamines (2020-04-28),

5. RE43327 - Hydrophobic polyamine analogs and methods for their use (2012-04-23),

Aminex Therapeutics, Inc. is a clinical stage biopharmaceutical company focused on developing innovative immunotherapies to treat cancer. Their lead product candidate is ATX-101, a novel fusion protein designed to harness the immune system to target and destroy tumor cells. The company is dedicated to advancing the field of oncology through cutting-edge research and development.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 16 2025

5 Patents

#2 in Kenmore, WA

#1,190 in Washington

#50,171 in US

Kenmore, WA, United States of America

Aminex Therapeutics, Inc.

Forward Citations = 10

3 inventors:

Mark R Burns (5 out of 6 patents)

Nand Baindur (1 out of 7 patents)

Gerard F Graminski (1 out of 5 patents)

4. Mark Robert Burns (1 patent)

Please report any incorrect information to support@idiyas.com

1 patent (CIPO):

Please report any incorrect information to support@idiyas.com

3 patents (EPO):

Please report any incorrect information to support@idiyas.com